Johnson Johnson AbbVie: Paths to Pharma Dominance
Johnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
Assess tax efficiency between index funds and target-date funds, including distributions and potential tax-optimized strategies for investors.
28,288 articlesJohnson & Johnson and AbbVie report divergent quarterly results, fueling a debate about two paths to pharma dominance...
A harsh winter trimmed fishing days and boosted costs for Maine’s lobster sector, even as 2025 revenue stayed above $...
Ford faced headwinds in its EV push, but a bold pivot could unlock durable value. Explore the battery storage strateg...
The hype around SpaceX often drowns out solid opportunities in AI-powered space companies. This guide shines a light ...
CFOs are increasingly moving into the CEO chair, but AI-driven disruption is testing how long they can stay. New data...
A high-profile Tampa real estate group is back with eXp Realty, rebranding as FIG Team Maximum Tampa and expanding it...
NVIDIA CEO Jensen Huang doubles down on AI’s role as a hiring accelerator, disputing calls for widespread job losses ...
When a tech giant moves its earnings date early, it often reveals more about where money is flowing than the numbers....
Coinbase is expanding the Ethereum ecosystem with Base, an Ethereum Layer-2 network designed for speed, low fees, an...
Salesforce has long been a growth leader in cloud software, but recent performance has cooled. This guide dives into ...
Three months after the Hormuz disruption, oil prices remain subdued. Record U.S. exports, a slowdown in Chinese deman...
June data reveal a surprising split: housing starts topped expectations while housing permits near cycle lows, hintin...